Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aims to evaluate whether vitamin D3 supplementation is associated with GPx activity, IL-6 levels, and clinical outcomes in patients with PCC, comparing the impact of bolus versus daily supplementation strategies.

Source: 1. Introduction. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were recruited from a post-COVID cohort at the National Institute of Respiratory Diseases (INER) and underwent direct clinical evaluation at the time of study enrollment.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of Vitamin D Supplementation with Glutathione Peroxidase (GPx) Activity, Interleukine-6 (IL-6) Levels, and Anxiety and Depression Scores in Patients with Post-COVID-19 Condition

Study design awaiting verification · International Journal of Molecular Sciences · 2025

Original publication title

Association of Vitamin D Supplementation with Glutathione Peroxidase (GPx) Activity, Interleukine-6 (IL-6) Levels, and Anxiety and Depression Scores in Patients with Post-COVID-19 Condition

Iván Ignacio-Mejía; Cindy Bandala; José Francisco González-Zamora; Leslie Chavez-Galan; Ivette Buendia-Roldan; Karina Pérez-Torres; María Zobeida Rodríguez-Díaz; Denilson Xipe Pacheco-Tobón; Saray Quintero-Fabián; Marco Antonio Vargas-Hernández; Humberto Carrasco-Vargas; Ramcés Falfán-Valencia; Gloria Pérez-Rubio; Kevin Alexis Hernández-Lara; Saúl Gómez-Manzo; Daniel Ortega-Cuellar; Fredy Ignacio-Mejía; Noemí Cárdenas-Rodríguez

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Coronavirus disease 2019 (COVID-19) presents with various symptoms, and some patients develop post-COVID-19 condition (PCC). Vitamin D has shown therapeutic potential in COVID-19 and may offer benefits for PCC. The aim of this study was to evaluate the differences associated with two supplementation strategies (bolus and daily) on interleukin-6 (IL-6) levels, glutathione peroxidase (GPx) activity, and clinical outcomes in PCC patients, regardless of whether target 25 (OH) D levels reached the ideal range. We conducted a self-controlled study in which 54 participants with PCC were supplemented with vitamin D3 (n = 28 bolus and n = 26 daily) for 2 months.

Blood samples were collected to measure IL-6 levels and GPx activity using spectrophotometric methods. The Hospital Anxiety and Depression Scale (HADS) was used to assess mental function. Both bolus and daily vitamin D supplementation were significantly associated with increased GPx activity and decreased IL-6 levels. Daily supplementation was additionally associated with a significant reduction in anxiety and depression scores. However, neither regimen was associated with improvements in cough, dyspnea, or fatigue. These findings suggest a potential association between vitamin D supplementation and improvements in antioxidant and neuropsychiatric parameters in PCC, possibly mediated by its immunomodulatory and antioxidant properties.

Further placebo-controlled trials are warranted to determine whether these observed associations reflect causal relationships.

Authors’ abstract

Coronavirus disease 2019 (COVID-19) presents with various symptoms, and some patients develop post-COVID-19 condition (PCC). Vitamin D has shown therapeutic potential in COVID-19 and may offer benefits for PCC. The aim of this study was to evaluate the differences associated with two supplementation strategies (bolus and daily) on interleukin-6 (IL-6) levels, glutathione peroxidase (GPx) activity, and clinical outcomes in PCC patients, regardless of whether target 25 (OH) D levels reached the ideal range. We conducted a self-controlled study in which 54 participants with PCC were supplemented with vitamin D3 (n = 28 bolus and n = 26 daily) for 2 months.

Blood samples were collected to measure IL-6 levels and GPx activity using spectrophotometric methods. The Hospital Anxiety and Depression Scale (HADS) was used to assess mental function. Both bolus and daily vitamin D supplementation were significantly associated with increased GPx activity and decreased IL-6 levels. Daily supplementation was additionally associated with a significant reduction in anxiety and depression scores. However, neither regimen was associated with improvements in cough, dyspnea, or fatigue. These findings suggest a potential association between vitamin D supplementation and improvements in antioxidant and neuropsychiatric parameters in PCC, possibly mediated by its immunomodulatory and antioxidant properties.

Further placebo-controlled trials are warranted to determine whether these observed associations reflect causal relationships.

Publication and source details

Original title: Association of Vitamin D Supplementation with Glutathione Peroxidase (GPx) Activity, Interleukine-6 (IL-6) Levels, and Anxiety and Depression Scores in Patients with Post-COVID-19 Condition

Iván Ignacio-Mejía; Cindy Bandala; José Francisco González-Zamora; Leslie Chavez-Galan; Ivette Buendia-Roldan; Karina Pérez-Torres; María Zobeida Rodríguez-Díaz; Denilson Xipe Pacheco-Tobón; Saray Quintero-Fabián; Marco Antonio Vargas-Hernández; Humberto Carrasco-Vargas; Ramcés Falfán-Valencia; Gloria Pérez-Rubio; Kevin Alexis Hernández-Lara; Saúl Gómez-Manzo; Daniel Ortega-Cuellar; Fredy Ignacio-Mejía; Noemí Cárdenas-Rodríguez

International Journal of Molecular Sciences · 2025

* Correspondence: ncardenasr@pediatria.gob.mx; Tel.: +52-55-10-840900 (ext. 1429)
†

These authors contributed equally to this work.

© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Escuela Militar de Graduados de Sanidad, (UDEFA), Mexico City, Mexico2022/C-015Instituto Nacional de Pediatría2022/C-015Instituto Nacional de Enfermedades Respiratorias Ismael Cosío VillegasC32-22Escuela Militar de Graduados de Sanidad, (UDEFA), Mexico City, Mexico; Instituto Nacional de Pediatría (INP, protocol number 2022/C-015) and Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER, Protocol number C32-22).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:00:18.169091+00:00

DOI: 10.3390/ijms26104582 · PMC12110956